Brainstorm Secures NurOwn-associated Patents in Several Markets

Brainstorm Secures NurOwn-associated Patents in Several Markets

297071

Brainstorm Secures NurOwn-associated Patents in Several Markets

In the past year, BrainStorm Cell Therapeutics was granted four patents and is waiting for a fifth, already accepted, meant to provide protection for its NurOwn cell therapy and technology in territories around the world. NurOwn is being tested in clinical trials as a potential treatment for multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS), another neurodegenerative disorder. Brainstorm also is conducting preclinical studies to assess the therapy’s potential in other neurodegenerative diseases, such as Parkinson’s…

You must be logged in to read/download the full post.